Valuation models
price $291.86 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused197.46 – 314.46243.8620% overvaluedDCF · Perpetuity growth · 10y232.52 – 366.88285.822% overvaluedDCF · EBITDA exit · 5y288.01 – 316.12301.693% undervaluedDCF · EBITDA exit · 10y311.31 – 368.46338.5214% undervaluedP/E · peers213.88 – 234.15230.7426% overvaluedP/E · own history480.33 – 558.44519.3944% undervaluedPEG—351.5317% undervaluedEV/EBITDA · peers185.46 – 209.82195.4449% overvaluedEV/Revenue · peers120.30 – 230.11177.8964% overvaluedEarnings power value83.52 – 138.18105.62176% overvaluedDividend discount69.85 – 167.79104.79179% overvaluedWall St. consensus target—339.0014% belowCost of capital (WACC)—7.85%—
DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
243.86
Stryker closed at $291.86 — overvalued by 20% vs model.
197.46the model's range314.46
DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
104.79 – 519.39
Wall St. target
339.00 14% below
Above model, 1y
31 of 31 days
How it is valued
Valued asMature & Stable
Moderate growth (~11% recent)Moderate margins (13% net margin)Pays dividendsHighly cyclical earnings
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.